Zhejiang Yongtai Technology Co .,: 2024 Interim Performance Forecast

Sensex a shareJul 10 12:00 ET · Announcements

Express News | Zhejiang Yongtai - Preliminary 2024 Interim Results Forecast

ReutersJul 10 05:09 ET

Zhejiang Yongtai Technology Co. (002326.SZ) expects a profit of 350-450 million yuan in the first half of the year.

On July 10, Gelon Hui announced the 2024 semi-annual performance forecast for Zhejiang Yongtai Technology (002326.SZ), with a net income attributable to shareholders of RMB 35 million to RMB 45 million and a year-on-year growth of -9.45% to 16.42%. After deducting non-recurring gains and losses, the net income is expected to be RMB 31 million to RMB 41 million, compared to a loss of RMB 42.0643 million in the same period last year; basic earnings per share are expected to be between RMB 0.038/share and RMB 0.049/share. During the reporting period, the market prices of the company's lithium battery material sector products, lithium hexafluorophosphate and raw material lithium carbonate, rose.

Gelonghui FinanceJul 10 04:48 ET

Zhejiang Yongtai Technology Co., Ltd. (002326.SZ): Plans to launch a 2024 restricted stock incentive plan for 12.31 million shares.

On June 28th, Gelunhui reported that Zhejiang Yongtai Technology Co. (002326.SZ) announced its 2024 Restricted Stock Incentive Plan (draft), which plans to grant 12.31 million restricted stocks to incentive objects, accounting for approximately 1.35% of the company's total share capital of 91,376,079.5 million shares on the announcement date of this incentive plan draft. This grant is a one-time grant with no reserved rights. The grant price for the restricted stocks in this incentive plan is 4.30 yuan/share. There are a total of 321 incentive objects in this incentive plan, including directors who hold positions in the company (including subsidiaries) at the time of announcement of this incentive plan.

Gelonghui FinanceJun 28 07:16 ET

Yongtai Technology's Pharmaceutical Arm Gets Nod for Two Drugs

Zhejiang Yongtai Pharmaceutical, a unit of Chinese chemical manufacturer Zhejiang Yongtai Technology (SHE:002326) received drug registration certificates for two drugs from China's National Medical Pr

MT NewswiresJun 26 05:13 ET

Yongtai Technology's Pharmaceutical Arm Gets Nod to Market Esomeprazole Magnesium Capsules

Zhejiang Yongtai Pharmaceutical, a unit of chemical manufacturer Zhejiang Yongtai Technology (SHE:002326), received a drug registration certificate for its esomeprazole magnesium enteric-coated capsul

MT NewswiresJun 14 03:25 ET